Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
639.85
Change Change %
-1.25 -0.19%

Updated:26 Sep, 2018, 15:44 PM IST

BSE
640.00
Change Change %
0.20 0.03%

Updated:26 Sep, 2018, 15:34 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
08-12-2015 Hold 775.00 817.00
N/A
Target Hit Custom
08-12-2016

Nomura upgrades Sun Pharma to neutral

Gleevec approval is in-line with expectation. Failure to scale speciality business presents a downside risk to long-term growth assumptions, hence valuation multiples. Regulatory update on Halol facility and realisation of Ranbaxy synergy are the key catalysts for the stock.

Top